Yousif Capital Management LLC lessened its position in shares of Cabot Corporation (NYSE:CBT – Free Report) by 3.0% in the second quarter, Holdings Channel.com reports. The fund owned 18,107 shares of the specialty chemicals company’s stock after selling 561 shares during the quarter. Yousif Capital Management LLC’s holdings in Cabot were worth $1,358,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in CBT. GAMMA Investing LLC grew its position in Cabot by 26.1% during the first quarter. GAMMA Investing LLC now owns 1,700 shares of the specialty chemicals company’s stock valued at $141,000 after acquiring an additional 352 shares during the period. Wealth Enhancement Advisory Services LLC grew its position in Cabot by 9.1% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 9,850 shares of the specialty chemicals company’s stock valued at $819,000 after acquiring an additional 819 shares during the period. Janney Montgomery Scott LLC purchased a new stake in Cabot during the first quarter valued at about $975,000. QRG Capital Management Inc. purchased a new stake in Cabot during the first quarter valued at about $482,000. Finally, Consolidated Planning Corp grew its position in Cabot by 80.4% during the first quarter. Consolidated Planning Corp now owns 9,431 shares of the specialty chemicals company’s stock valued at $784,000 after acquiring an additional 4,204 shares during the period. Hedge funds and other institutional investors own 93.18% of the company’s stock.
Cabot Trading Up 1.4%
NYSE:CBT opened at $70.64 on Tuesday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.41 and a current ratio of 2.13. Cabot Corporation has a one year low of $66.50 and a one year high of $117.46. The business’s 50-day simple moving average is $77.19 and its 200 day simple moving average is $76.60. The stock has a market cap of $3.76 billion, a price-to-earnings ratio of 9.23 and a beta of 0.88.
Insider Activity at Cabot
In related news, CEO Sean D. Keohane sold 114,436 shares of the business’s stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $79.28, for a total value of $9,072,486.08. Following the transaction, the chief executive officer owned 361,518 shares in the company, valued at approximately $28,661,147.04. The trade was a 24.04% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 3.03% of the company’s stock.
Wall Street Analyst Weigh In
CBT has been the subject of several analyst reports. UBS Group set a $82.00 target price on Cabot and gave the stock a “neutral” rating in a research report on Tuesday, August 5th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a research report on Wednesday, October 8th. Finally, Mizuho decreased their target price on Cabot from $90.00 to $88.00 and set an “outperform” rating for the company in a research report on Friday, October 3rd. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Cabot currently has an average rating of “Hold” and an average target price of $85.00.
Get Our Latest Stock Report on CBT
Cabot Company Profile
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Further Reading
- Five stocks we like better than Cabot
- How to Profit From Value Investing
- Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done Yet
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- 3 High-Yield Banks for Investors to Buy on the Dip
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 5 Surprising Stocks Set to Benefit From a Future Robotics Boom
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.